PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 216 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $27 | -30.8% | 20,000 | +91.1% | 0.00% | -25.0% |
Q1 2024 | $39 | -70.9% | 10,463 | -34.6% | 0.00% | -66.7% |
Q3 2023 | $134 | -3.6% | 16,000 | -5.9% | 0.01% | 0.0% |
Q4 2022 | $139 | -99.9% | 17,000 | -61.8% | 0.01% | 0.0% |
Q2 2022 | $197,000 | -27.8% | 44,549 | +48.5% | 0.01% | -14.3% |
Q1 2022 | $273,000 | -98.2% | 30,000 | -98.0% | 0.01% | -98.9% |
Q3 2020 | $15,001,000 | -19.6% | 1,519,832 | -71.9% | 1.27% | -25.7% |
Q2 2020 | $18,660,000 | +12.0% | 5,408,764 | -0.6% | 1.72% | +42.4% |
Q1 2020 | $16,657,000 | -31.3% | 5,443,564 | +15.4% | 1.20% | -28.8% |
Q4 2019 | $24,255,000 | +2.4% | 4,718,964 | +2.8% | 1.69% | +14.9% |
Q3 2019 | $23,685,000 | -49.5% | 4,590,150 | -40.8% | 1.47% | +35.5% |
Q2 2019 | $46,928,000 | -10.4% | 7,756,672 | +7.0% | 1.09% | -24.0% |
Q1 2019 | $52,398,000 | +418.9% | 7,247,354 | +431.1% | 1.43% | +90.2% |
Q4 2018 | $10,098,000 | – | 1,364,531 | – | 0.75% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madrone Advisors, LLC | 16,415,933 | $218,331,909 | 38.11% |
ORACLE INVESTMENT MANAGEMENT INC | 2,015,495 | $26,806,084 | 19.75% |
Decheng Capital Management III (Cayman), LLC | 1,463,872 | $19,469,498 | 6.11% |
Iron Triangle Partners LP | 2,400,000 | $31,920,000 | 4.27% |
Jackson Square Partners, LLC | 8,517,624 | $113,284,399 | 3.30% |
BOURNE LENT ASSET MANAGEMENT INC | 580,000 | $7,714,000 | 2.69% |
ARK Investment Management | 26,634,620 | $354,240,443 | 2.34% |
ARDSLEY ADVISORY PARTNERS LP | 906,000 | $12,049,800 | 2.04% |
Avidity Partners Management LP | 4,337,400 | $57,687,420 | 2.02% |
Nikko Asset Management Americas, Inc. | 13,649,948 | $181,271,309 | 1.91% |